Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

Ito, K., Scott, S.A., Cutler, S., Dong, L.-F., Neužil, J., Blanchard, H., Ralph, S.J. Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis. 2011, 14(3), 293-307. ISSN 0969-6970. E-ISSN 1573-7209. Dostupné z: doi: 10.1007/s10456-011-9213-5